Skip to main content
Fig. 2 | Critical Care

Fig. 2

From: The soluble mannose receptor (sMR/sCD206) in critically ill patients with invasive fungal infections, bacterial infections or non-infectious inflammation: a secondary analysis of the EPaNIC RCT

Fig. 2

The sMR concentration on the day of antimicrobial initiation or matched ICU day. Serum concentrations are shown for healthy controls and for patients. For patients, concentrations are shown on the day of initiation of antimicrobial treatment in the groups with fungal or bacterial infection and on the matched day of ICU stay in the group with non-infectious inflammation. Statistical analyses have been performed with the student t-test after double square root transformation to obtain a normal distribution

Back to article page